Searched for
JUBILANT LIFESCIENCES
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
Share market update: 41 stocks hit 52-week highs on NSEOverall, 14 shares were trading in green in Nifty50 index, while 36 were trading in red.
Buy Jubilant Life Sciences, target Rs 980: HDFC SecuritiesBuy Jubilant Life Sciences at a price target of Rs 980.
Buy Jubilant Life Sciences, target Rs 1004: ICICI SecuritiesBuy Jubilant Life Sciences Ltd. at a price target of Rs 1004..
Jubilant Life Sciences raises $300 million via bond issuanceThe issue is said to have attracted high quality investors including private banks and asset management companies such as Fidelity and HSBC...
- Buy Jubilant Life Sciences, target Rs 352.0 : Kunal Bothra
Buy Jubilant Life Sciences Ltd. at a price target of Rs 352.0 and a stop loss at Rs 336.0 from entry point
- Buy Jubilant Life Sciences, target Rs 318: Microsec Capital
Buy Jubilant Life Sciences Ltd. at a price target of Rs 318 and a stop loss at Rs 309
Jubilant Lifesciences gains as company calls off deal with CyclopharmShares of Jubilant Life Sciences surged 4 per cent in Thursday's trade after the company its wholly-owned subsidiary and Australia-based Cy...
- Buy Jubilant Life Sciences Ltd with a target of Rs 410: Ashwani Gujral
"Jubilant Life Sciences Ltd is a 'BUY' call with a target of Rs 410 and a stop loss of Rs 388."
- Buy Jubilant Life Sciences Ltd with a target of Rs 415: Ashwani Gujral
"Jubilant Life Sciences Ltd is a 'BUY' call with a target of Rs 415 and a stop loss of Rs of 390."
- Buy Jubilant Life with a target of Rs 375: Ashwani Gujral
'Jubilant Life Sciences Ltd. is a 'BUY' call with a target of Rs 375 and a stop loss of Rs 350'
- Buy Jubilant Lifesciences with a target of Rs 330: Ashwani Gujral
'Jubilant Lifesciences is a 'BUY' call with a target of Rs 330 and a stop loss of Rs 295'
Jubilant Life Q4 net dips 57% to Rs 43 croreJubilant Life Sciences today posted a 56.75 per cent decline in consolidated net profit at Rs 42.73 crore for the fourth quarter of 2014-15...
- Jubilant Life Q3 net loss at Rs 78.39 crore
Jubilant Life Sciences said it has posted consolidated net loss of Rs 78.39 crore for the quarter ended December 31, mainly due to forex lo...
- Jubilant Lifesciences: Wait for June quarter nos before placing your bet
Investors can look at accumulating it, but with a clear eye on whether there is improvement in performance in the June quarter.
- Jubilant Life Sciences eyes double digit growth this fiscal: MD
In an interview with ET Now, Shyam S Bhartia, Chairman and MD, Jubilant Life Sciences, talks about the company's order book and future stra...
- Jubilant Life repays $202 mn for outstanding FCCBs
Jubilant Life Sciences today said it has repayed $202 million (nearly Rs 900 crore) for redemption of outstanding overseas bonds.
- Jubilant Life Sciences has done too much on the downside: Deepak Mohoni
Jubilant Life Sciences has fallen from Rs 450 to Rs 150 in about 1.5 years.
- Jubilant Life Sciences to set up plant in SEZ; stock up
Jubilant Life Sciences is setting up a manufacturing plant for Symtet/TCP of 24,000 TPA capacity and Chlorinated Pyridine derivatives of 50...
- Jubilant Life Sciences Q3 net profit at Rs 44 cr
Shares of both Jubilant Life Sciences and Jubilant Industries Limited are now listed on Bombay Stock Exchange and National Stock Exchange.